Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL

K-Number: K252114 · 2025-10-02

Decision Date2025-10-02
Product CodeJWY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL is a medical device manufactured by Liofilchem s.r.l.. It received FDA 510(k) clearance on 2025-10-02 under approval number K252114. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL?

MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL is a medical device that received FDA 510(k) clearance on 2025-10-02. It is manufactured by Liofilchem s.r.l.. The 510(k) number is K252114.

When was MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL approved by the FDA?

MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL received FDA 510(k) clearance on 2025-10-02, under approval number K252114.

What company makes MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL?

MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL is manufactured by Liofilchem s.r.l..

What is the FDA product code for MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL?

The FDA product code for MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL is JWY.

Other Devices by Liofilchem s.r.l.

View all 35 devices →

Related Devices (Code: JWY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.